 | • レポートコード：GIR-107A15015 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ラコサミドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ラコサミドの種類別市場規模（経口錠剤、経口液剤、静脈内）、用途別市場規模（成人、小児患者）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ラコサミドの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：UCB、Teva、Amneal Pharmaceuticals、MSN Laboratories、Alembic Pharma、Glenmark、Aurobindo Pharma、Accord Healthcare、Mylan、Sun Pharma、Apotex ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口錠剤、経口液剤、静脈内 ・用途別分析2016年-2026年：成人、小児患者 ・ラコサミドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ラコサミドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ラコサミドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ラコサミドの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ラコサミドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Lacosamide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Lacosamide size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Lacosamide market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Lacosamide market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral tablets
Oral solution
Intravenous
Market segment by Application, can be divided into
Adults
Pediatric patients
Market segment by players, this report covers
UCB
Teva
Amneal Pharmaceuticals
MSN Laboratories
Alembic Pharma
Glenmark
Aurobindo Pharma
Accord Healthcare
Mylan
Sun Pharma
Apotex
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Lacosamide
1.2 Classification of Lacosamide by Type
1.2.1 Overview: Global Lacosamide Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Lacosamide Revenue Market Share by Type in 2020
1.2.3 Oral tablets
1.2.4 Oral solution
1.2.5 Intravenous
1.3 Global Lacosamide Market by Application
1.3.1 Overview: Global Lacosamide Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Global Lacosamide Market Size & Forecast
1.5 Global Lacosamide Market Size and Forecast by Region
1.5.1 Global Lacosamide Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Lacosamide Market Size by Region, (2016-2021)
1.5.3 North America Lacosamide Market Size and Prospect (2016-2026)
1.5.4 Europe Lacosamide Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Lacosamide Market Size and Prospect (2016-2026)
1.5.6 South America Lacosamide Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Lacosamide Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Lacosamide Market Drivers
1.6.2 Lacosamide Market Restraints
1.6.3 Lacosamide Trends Analysis
2 Company Profiles
2.1 UCB
2.1.1 UCB Details
2.1.2 UCB Major Business
2.1.3 UCB Lacosamide Product and Solutions
2.1.4 UCB Lacosamide Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 UCB Recent Developments and Future Plans
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Lacosamide Product and Solutions
2.2.4 Teva Lacosamide Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Teva Recent Developments and Future Plans
2.3 Amneal Pharmaceuticals
2.3.1 Amneal Pharmaceuticals Details
2.3.2 Amneal Pharmaceuticals Major Business
2.3.3 Amneal Pharmaceuticals Lacosamide Product and Solutions
2.3.4 Amneal Pharmaceuticals Lacosamide Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Amneal Pharmaceuticals Recent Developments and Future Plans
2.4 MSN Laboratories
2.4.1 MSN Laboratories Details
2.4.2 MSN Laboratories Major Business
2.4.3 MSN Laboratories Lacosamide Product and Solutions
2.4.4 MSN Laboratories Lacosamide Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 MSN Laboratories Recent Developments and Future Plans
2.5 Alembic Pharma
2.5.1 Alembic Pharma Details
2.5.2 Alembic Pharma Major Business
2.5.3 Alembic Pharma Lacosamide Product and Solutions
2.5.4 Alembic Pharma Lacosamide Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Alembic Pharma Recent Developments and Future Plans
2.6 Glenmark
2.6.1 Glenmark Details
2.6.2 Glenmark Major Business
2.6.3 Glenmark Lacosamide Product and Solutions
2.6.4 Glenmark Lacosamide Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Glenmark Recent Developments and Future Plans
2.7 Aurobindo Pharma
2.7.1 Aurobindo Pharma Details
2.7.2 Aurobindo Pharma Major Business
2.7.3 Aurobindo Pharma Lacosamide Product and Solutions
2.7.4 Aurobindo Pharma Lacosamide Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Aurobindo Pharma Recent Developments and Future Plans
2.8 Accord Healthcare
2.8.1 Accord Healthcare Details
2.8.2 Accord Healthcare Major Business
2.8.3 Accord Healthcare Lacosamide Product and Solutions
2.8.4 Accord Healthcare Lacosamide Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Accord Healthcare Recent Developments and Future Plans
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Lacosamide Product and Solutions
2.9.4 Mylan Lacosamide Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Mylan Recent Developments and Future Plans
2.10 Sun Pharma
2.10.1 Sun Pharma Details
2.10.2 Sun Pharma Major Business
2.10.3 Sun Pharma Lacosamide Product and Solutions
2.10.4 Sun Pharma Lacosamide Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Sun Pharma Recent Developments and Future Plans
2.11 Apotex
2.11.1 Apotex Details
2.11.2 Apotex Major Business
2.11.3 Apotex Lacosamide Product and Solutions
2.11.4 Apotex Lacosamide Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Apotex Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Lacosamide Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Lacosamide Players Market Share
3.2.2 Top 10 Lacosamide Players Market Share
3.2.3 Market Competition Trend
3.3 Lacosamide Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Lacosamide Revenue and Market Share by Type (2016-2021)
4.2 Global Lacosamide Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Lacosamide Revenue Market Share by Application (2016-2021)
5.2 Lacosamide Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Lacosamide Revenue by Type (2016-2026)
6.2 North America Lacosamide Revenue by Application (2016-2026)
6.3 North America Lacosamide Market Size by Country
6.3.1 North America Lacosamide Revenue by Country (2016-2026)
6.3.2 United States Lacosamide Market Size and Forecast (2016-2026)
6.3.3 Canada Lacosamide Market Size and Forecast (2016-2026)
6.3.4 Mexico Lacosamide Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Lacosamide Revenue by Type (2016-2026)
7.2 Europe Lacosamide Revenue by Application (2016-2026)
7.3 Europe Lacosamide Market Size by Country
7.3.1 Europe Lacosamide Revenue by Country (2016-2026)
7.3.2 Germany Lacosamide Market Size and Forecast (2016-2026)
7.3.3 France Lacosamide Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Lacosamide Market Size and Forecast (2016-2026)
7.3.5 Russia Lacosamide Market Size and Forecast (2016-2026)
7.3.6 Italy Lacosamide Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Lacosamide Revenue by Type (2016-2026)
8.2 Asia-Pacific Lacosamide Revenue by Application (2016-2026)
8.3 Asia-Pacific Lacosamide Market Size by Region
8.3.1 Asia-Pacific Lacosamide Revenue by Region (2016-2026)
8.3.2 China Lacosamide Market Size and Forecast (2016-2026)
8.3.3 Japan Lacosamide Market Size and Forecast (2016-2026)
8.3.4 South Korea Lacosamide Market Size and Forecast (2016-2026)
8.3.5 India Lacosamide Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Lacosamide Market Size and Forecast (2016-2026)
8.3.7 Australia Lacosamide Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Lacosamide Revenue by Type (2016-2026)
9.2 South America Lacosamide Revenue by Application (2016-2026)
9.3 South America Lacosamide Market Size by Country
9.3.1 South America Lacosamide Revenue by Country (2016-2026)
9.3.2 Brazil Lacosamide Market Size and Forecast (2016-2026)
9.3.3 Argentina Lacosamide Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Lacosamide Revenue by Type (2016-2026)
10.2 Middle East & Africa Lacosamide Revenue by Application (2016-2026)
10.3 Middle East & Africa Lacosamide Market Size by Country
10.3.1 Middle East & Africa Lacosamide Revenue by Country (2016-2026)
10.3.2 Turkey Lacosamide Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Lacosamide Market Size and Forecast (2016-2026)
10.3.4 UAE Lacosamide Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Lacosamide Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Lacosamide Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Lacosamide Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Lacosamide Revenue (USD Million) by Region (2016-2021)
Table 5. Global Lacosamide Revenue Market Share by Region (2021-2026)
Table 6. UCB Corporate Information, Head Office, and Major Competitors
Table 7. UCB Major Business
Table 8. UCB Lacosamide Product and Solutions
Table 9. UCB Lacosamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Teva Corporate Information, Head Office, and Major Competitors
Table 11. Teva Major Business
Table 12. Teva Lacosamide Product and Solutions
Table 13. Teva Lacosamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Amneal Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 15. Amneal Pharmaceuticals Major Business
Table 16. Amneal Pharmaceuticals Lacosamide Product and Solutions
Table 17. Amneal Pharmaceuticals Lacosamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. MSN Laboratories Corporate Information, Head Office, and Major Competitors
Table 19. MSN Laboratories Major Business
Table 20. MSN Laboratories Lacosamide Product and Solutions
Table 21. MSN Laboratories Lacosamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Alembic Pharma Corporate Information, Head Office, and Major Competitors
Table 23. Alembic Pharma Major Business
Table 24. Alembic Pharma Lacosamide Product and Solutions
Table 25. Alembic Pharma Lacosamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Glenmark Corporate Information, Head Office, and Major Competitors
Table 27. Glenmark Major Business
Table 28. Glenmark Lacosamide Product and Solutions
Table 29. Glenmark Lacosamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Aurobindo Pharma Corporate Information, Head Office, and Major Competitors
Table 31. Aurobindo Pharma Major Business
Table 32. Aurobindo Pharma Lacosamide Product and Solutions
Table 33. Aurobindo Pharma Lacosamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Accord Healthcare Corporate Information, Head Office, and Major Competitors
Table 35. Accord Healthcare Major Business
Table 36. Accord Healthcare Lacosamide Product and Solutions
Table 37. Accord Healthcare Lacosamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Mylan Corporate Information, Head Office, and Major Competitors
Table 39. Mylan Major Business
Table 40. Mylan Lacosamide Product and Solutions
Table 41. Mylan Lacosamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Sun Pharma Corporate Information, Head Office, and Major Competitors
Table 43. Sun Pharma Major Business
Table 44. Sun Pharma Lacosamide Product and Solutions
Table 45. Sun Pharma Lacosamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Apotex Corporate Information, Head Office, and Major Competitors
Table 47. Apotex Major Business
Table 48. Apotex Lacosamide Product and Solutions
Table 49. Apotex Lacosamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Lacosamide Revenue (USD Million) by Players (2019-2021)
Table 51. Global Lacosamide Revenue Share by Players (2019-2021)
Table 52. Breakdown of Lacosamide by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Lacosamide Players Head Office, Products and Services Provided
Table 54. Lacosamide Mergers & Acquisitions in the Past Five Years
Table 55. Lacosamide New Entrants and Expansion Plans
Table 56. Global Lacosamide Revenue (USD Million) by Type (2016-2021)
Table 57. Global Lacosamide Revenue Share by Type (2016-2021)
Table 58. Global Lacosamide Revenue Forecast by Type (2021-2026)
Table 59. Global Lacosamide Revenue by Application (2016-2021)
Table 60. Global Lacosamide Revenue Forecast by Application (2021-2026)
Table 61. North America Lacosamide Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Lacosamide Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Lacosamide Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Lacosamide Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Lacosamide Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Lacosamide Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Lacosamide Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Lacosamide Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Lacosamide Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Lacosamide Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Lacosamide Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Lacosamide Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Lacosamide Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Lacosamide Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Lacosamide Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Lacosamide Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Lacosamide Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Lacosamide Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Lacosamide Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Lacosamide Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Lacosamide Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Lacosamide Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Lacosamide Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Lacosamide Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Lacosamide Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Lacosamide Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Lacosamide Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Lacosamide Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Lacosamide Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Lacosamide Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Lacosamide Picture
Figure 2. Global Lacosamide Revenue Market Share by Type in 2020
Figure 3. Oral tablets
Figure 4. Oral solution
Figure 5. Intravenous
Figure 6. Lacosamide Revenue Market Share by Application in 2020
Figure 7. Adults Picture
Figure 8. Pediatric patients Picture
Figure 9. Global Lacosamide Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Lacosamide Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Lacosamide Revenue Market Share by Region (2016-2026)
Figure 12. Global Lacosamide Revenue Market Share by Region in 2020
Figure 13. North America Lacosamide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Lacosamide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Lacosamide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Lacosamide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Lacosamide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Lacosamide Market Drivers
Figure 19. Lacosamide Market Restraints
Figure 20. Lacosamide Market Trends
Figure 21. UCB Recent Developments and Future Plans
Figure 22. Teva Recent Developments and Future Plans
Figure 23. Amneal Pharmaceuticals Recent Developments and Future Plans
Figure 24. MSN Laboratories Recent Developments and Future Plans
Figure 25. Alembic Pharma Recent Developments and Future Plans
Figure 26. Glenmark Recent Developments and Future Plans
Figure 27. Aurobindo Pharma Recent Developments and Future Plans
Figure 28. Accord Healthcare Recent Developments and Future Plans
Figure 29. Mylan Recent Developments and Future Plans
Figure 30. Sun Pharma Recent Developments and Future Plans
Figure 31. Apotex Recent Developments and Future Plans
Figure 32. Global Lacosamide Revenue Share by Players in 2020
Figure 33. Lacosamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Lacosamide Revenue Market Share in 2020
Figure 35. Global Top 10 Players Lacosamide Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Lacosamide Revenue Share by Type in 2020
Figure 38. Global Lacosamide Market Share Forecast by Type (2021-2026)
Figure 39. Global Lacosamide Revenue Share by Application in 2020
Figure 40. Global Lacosamide Market Share Forecast by Application (2021-2026)
Figure 41. North America Lacosamide Sales Market Share by Type (2016-2026)
Figure 42. North America Lacosamide Sales Market Share by Application (2016-2026)
Figure 43. North America Lacosamide Revenue Market Share by Country (2016-2026)
Figure 44. United States Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Lacosamide Sales Market Share by Type (2016-2026)
Figure 48. Europe Lacosamide Sales Market Share by Application (2016-2026)
Figure 49. Europe Lacosamide Revenue Market Share by Country (2016-2026)
Figure 50. Germany Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Lacosamide Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Lacosamide Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Lacosamide Revenue Market Share by Region (2016-2026)
Figure 58. China Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Lacosamide Sales Market Share by Type (2016-2026)
Figure 65. South America Lacosamide Sales Market Share by Application (2016-2026)
Figure 66. South America Lacosamide Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Lacosamide Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Lacosamide Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Lacosamide Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Lacosamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のエトラビリン市場 2021：企業別、地域別、種類・用途別 The Etravirine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …- 世界の経口免疫賦活剤市場 2021：企業別、地域別、種類・用途別 The Oral Immunostimulant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界の口用美容＆健康製品市場 2021：企業別、地域別、種類・用途別 The Oral Beauty and Health Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界のうがい薬市場 2021：企業別、地域別、種類・用途別 The Oral Rinse market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …
- 世界のルフィナミド市場 2021：企業別、地域別、種類・用途別 The Rufinamide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …